Home/PaxMedica/David H. Chung

DH

David H. Chung

Chief Medical Officer

Therapeutic Areas

Neurology Psychiatry

PaxMedica Pipeline

Drug	Indication	Phase
PAX-101 (IV suramin)	Autism Spectrum Disorder (ASD)	Phase 3

Leadership Team at PaxMedica

Chairman and Chief Executive Officer

Stephen D. Sheldon

Chief Financial Officer

Executive Chairman of the Board (previously)

Former Chief Operating Officer

Charles J. Casamento

View full PaxMedica profile